Comparing Post-Transplant Cyclophosphamide As GVHD Prophylaxis to Standard of Care for Acute Leukemia Patients

Clinical trial NCT04314219 · RECRUITING

Trial details

NCT number: NCT04314219
Sponsor: King Faisal Specialist Hospital & Research Center
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Acute Lymphoblastic Leukemia (ALL) in Complete Remission Acute Myeloid Leukemia (AML) in Remission

Start date: 2021-08-15
Primary completion: 2025-12-01
Enrollment: 264

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.